[ad_1] Pfizer released a first snapshot of its Phase 3 studies for its coronavirus vaccine on Monday and said the results look promising with data suggesting it is 90% effective at preventing the virus. The company and its collaborator BioNTech may now be on track to file an emergency use …
Read More »Pfizer and Biontech vaccine, over 90% efficacy against COVID-19. EMERGENCY request. It happens in the THIRD week of NOVEMBER
[ad_1] Pharmaceutical giant Pfizer made the long-awaited announcement. The vaccine, developed by Pfizer and Biontech, in the third phase of the test, was found, after an interim analysis, more than 90% effective in preventing COVID-19 infection in participants who had not previously been infected with SARS-COV -2. The study was …
Read More »